A new method that prevents the loss of silencing activity of double-strand RNA in humans
Since the discovery that short double-strand RNA molecules (siRNAs) can trigger sequence-specific degradation of target RNA in cells, great efforts are going on throughout the world to use siRNAs in human therapy.
The group of Dr. Dr. Albrecht Piiper at the Saarland University discovered a way to defend double-stranded and partial double-stranded molecules of RNA – particularly siRNAs – from degradation by RNAse in mammalian body fluid including humans.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/9386376
Contact
Dipl.-Kfm. Axel Koch MBA, Dr. Dirk Schwingel
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Self-Destructing Cancer Cells: Cutting-Edge RNA Breakthrough
Jülich scientists use novel RNA technology to selectively switch off tumours in the brain. An Adaptable Platform Technology That Destroys Glioblastoma Cancer Cells Using a special RNA molecule, a team…
Endurance Training: Transforming Lives of Heart Failure Patients
Can strength and endurance training be beneficial for patients with a certain form of heart failure? A research team from Greifswald investigated this question together with seven other research centers…
A Wake-Up Call for Mediterranean Shark Protection Against Extinction
Overfishing, illegal fishing and increasing marketing of shark meat pose significant threats to the more than 80 species of sharks and rays that inhabit the Mediterranean Sea, according to a…